Diplomat Pharmacy Inc. (DPLO)

3.10
NYSE : Health Services
Prev Close 6.20
Day Low/High 2.43 / 3.24
52 Wk Low/High 4.17 / 17.01
Avg Volume 739.60K
Exchange NYSE
Shares Outstanding 75.83M
Market Cap 470.15M
EPS -4.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Diplomat To Release Third-Quarter 2019 Operating Results Nov. 12

Diplomat To Release Third-Quarter 2019 Operating Results Nov. 12

FLINT, Mich., Oct.

Diplomat Announces Sale Of Certain Assets Of Envoy Health Management, LLC To Diligent Health Solutions, LLC

Diplomat Announces Sale Of Certain Assets Of Envoy Health Management, LLC To Diligent Health Solutions, LLC

The nation's largest independent provider of specialty pharmacy services sells certain assets to Diligent Health Solutions, LLC

Diplomat Announces Promotion Of David Skomo To Chief Operating Officer Of CastiaRx

Diplomat Announces Promotion Of David Skomo To Chief Operating Officer Of CastiaRx

Following the retirement of Chris Luthin, David Skomo Appointed COO at CastiaRx.

First Week Of DPLO October 18th Options Trading

First Week Of DPLO October 18th Options Trading

Investors in Diplomat Pharmacy Inc saw new options begin trading this week, for the October 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DPLO options chain for the new October 18th contracts and identified the following call contract of particular interest.

Diplomat Announces 2nd Quarter Financial Results; Updates 2019 Guidance

Diplomat Announces 2nd Quarter Financial Results; Updates 2019 Guidance

2nd Quarter Revenue of $1,288 Million, compared to $1,416 Million, Net Loss of $159.5 Million, compared to a Net Loss of $4.0 Million, Adjusted EBITDA of $19.3 Million, compared to $42.7 Million

Diplomat Announces Review Of Strategic Alternatives

Diplomat Announces Review Of Strategic Alternatives

FLINT, Mich., Aug.

Diplomat Signs Exclusive Practice-based Infusion Agreement With Allergy Partners

Diplomat Signs Exclusive Practice-based Infusion Agreement With Allergy Partners

This innovative agreement forms the nation's first large-scale physician practice-based infusion program.

Diplomat To Release Second-Quarter 2019 Operating Results August 9

Diplomat To Release Second-Quarter 2019 Operating Results August 9

FLINT, Mich., July 18, 2019 /PRNewswire/ --  Diplomat Pharmacy, Inc.

(DPLO) Alert: Johnson Fistel, LLP Announces Investigation Of Diplomat Pharmacy, Inc.; Long Term Investors Encouraged To Contact Firm

(DPLO) Alert: Johnson Fistel, LLP Announces Investigation Of Diplomat Pharmacy, Inc.; Long Term Investors Encouraged To Contact Firm

SAN DIEGO, July 15, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential violations of federal and state laws by Diplomat Pharmacy, Inc.

Diplomat Launches Empower Ecosystem Patient Support Digital Library

Diplomat Launches Empower Ecosystem Patient Support Digital Library

The nation's largest independent specialty pharmacy and infusion services provider launches a digital library of resources and tools for patients and caregivers.

Interesting DPLO Put And Call Options For February 2020

Interesting DPLO Put And Call Options For February 2020

Investors in Diplomat Pharmacy Inc saw new options begin trading this week, for the February 2020 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Diplomat Pharmacy Enters Oversold Territory (DPLO)

Diplomat Pharmacy Enters Oversold Territory (DPLO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting DPLO Put Options For July 19th

Interesting DPLO Put Options For July 19th

Investors in Diplomat Pharmacy Inc saw new options begin trading this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DPLO options chain for the new July 19th contracts and identified the following put contract of particular interest.

THURSDAY DEADLINE REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Diplomat Pharmacy, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

THURSDAY DEADLINE REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Diplomat Pharmacy, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Diplomat Pharmacy, Inc.

Bullish Jobs Data: Cramer's 'Mad Money' Recap (Friday 4/5/19)

Bullish Jobs Data: Cramer's 'Mad Money' Recap (Friday 4/5/19)

It's the right amount of growth and wage gains, says Jim Cramer. And here's your game plan for next week.

Roku, FireEye, Bloom Energy: 'Mad Money' Lightning Round

Roku, FireEye, Bloom Energy: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Roku, FireEye, Bloom Energy, Diplomat Pharmacy, People's Bank, TG Therapeutics, Tenneco, World Wrestling Entertainment, Optinose and more.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Diplomat Pharmacy, Inc.

DIPLOMAT PHARMACY SHAREHOLDER ALERT: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO

DIPLOMAT PHARMACY SHAREHOLDER ALERT: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Diplomat Pharmacy, Inc.

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Actions Against Diplomat Pharmacy, Inc. (DPLO)

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Actions Against Diplomat Pharmacy, Inc. (DPLO)

Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is notifying investors that class action lawsuits have been filed against Diplomat Pharmacy, Inc.

Deadline Reminder: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Diplomat Pharmacy, Inc.

Deadline Reminder: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Diplomat Pharmacy, Inc.

Law Offices of Howard G. Smith reminds investors of the upcoming  April 25, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Diplomat Pharmacy, Inc.

INVESTOR ALERT: Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Diplomat Pharmacy, Inc. Investors

INVESTOR ALERT: Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Diplomat Pharmacy, Inc. Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Diplomat Pharmacy, Inc.

First Week Of DPLO November 15th Options Trading

First Week Of DPLO November 15th Options Trading

Investors in Diplomat Pharmacy Inc saw new options become available this week, for the November 15th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Oversold Conditions For Diplomat Pharmacy (DPLO)

Oversold Conditions For Diplomat Pharmacy (DPLO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Diplomat Pharmacy, Inc.

TheStreet Quant Rating: D (Sell)